Landscapes / Targets

TYK2

7 drugs act on TYK2, in 48 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs7

DrugHow it worksCompanyStageNext dateDetails
Janus kinase inhibitor
Bristol Myers Squibb · Public BMY
Approved 18 Nov 2026soonPhase 3 trial completes
Tyrosine kinase inhibitor
Approved 11 Dec 2026soonPhase 2 trial completes
Janus kinase inhibitor
Priovant Therapeutics +1 · Public PFE
Approved 31 Dec 2028Phase 2/3 trial completes
Janus kinase inhibitor
Phase 3 5 Feb 2027Phase 2 trial completes
—
Phase 3 12 Jul 2027Phase 3 trial completes
—
Phase 3 Aug 2027Phase 2 trial completes
Pacritinibnot checked
Kinase inhibitor
Phase 2 Jul 2028Phase 2 trial completes

About this list

Checked
6 of 7 drugs. The other 1 is marked “not checked” in the list. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow TYK2

Following is part of Solo: you see every change to TYK2 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in